These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Excerpt from the 2022 American Association for the Study of Liver Diseases clinical practice guideline: management of primary sclerosing cholangitis and cholangiocarcinoma]. Yuan J; Han GH Zhonghua Gan Zang Bing Za Zhi; 2023 Jan; 31(1):35-41. PubMed ID: 36948847 [TBL] [Abstract][Full Text] [Related]
4. Primary sclerosing cholangitis and malignancy. Boberg KM; Lind GE Best Pract Res Clin Gastroenterol; 2011 Dec; 25(6):753-64. PubMed ID: 22117640 [TBL] [Abstract][Full Text] [Related]
5. Risk of hepato-pancreato-biliary cancer is increased by primary sclerosing cholangitis in patients with inflammatory bowel disease: A population-based cohort study. Yu J; Refsum E; Helsingen LM; Folseraas T; Ploner A; Wieszczy P; Barua I; Jodal HC; Melum E; Løberg M; Blom J; Bretthauer M; Adami HO; Kalager M; Ye W United European Gastroenterol J; 2022 Mar; 10(2):212-224. PubMed ID: 35107865 [TBL] [Abstract][Full Text] [Related]
6. Hepatobiliary and coexisting pancreatic duct abnormalities in patients with inflammatory bowel disease. Heikius B; Niemelä S; Lehtola J; Karttunen T; Lähde S Scand J Gastroenterol; 1997 Feb; 32(2):153-61. PubMed ID: 9051876 [TBL] [Abstract][Full Text] [Related]
7. [Biliary diseases - new insights and developments]. Weismüller TJ; Lankisch TO Dtsch Med Wochenschr; 2011 Apr; 136(14):713-6. PubMed ID: 21448834 [TBL] [Abstract][Full Text] [Related]
8. Hepatobiliary manifestations of inflammatory bowel disease. Raj V; Lichtenstein DR Gastroenterol Clin North Am; 1999 Jun; 28(2):491-513. PubMed ID: 10372279 [TBL] [Abstract][Full Text] [Related]
9. Hepatobiliary disease in inflammatory bowel disease. Ahmad J; Slivka A Gastroenterol Clin North Am; 2002 Mar; 31(1):329-45. PubMed ID: 12122741 [TBL] [Abstract][Full Text] [Related]
15. Hepatobiliary manifestations in inflammatory bowel disease: the gut, the drugs and the liver. Rojas-Feria M; Castro M; Suárez E; Ampuero J; Romero-Gómez M World J Gastroenterol; 2013 Nov; 19(42):7327-40. PubMed ID: 24259964 [TBL] [Abstract][Full Text] [Related]
16. Cholangiocarcinoma in patients with primary sclerosing cholangitis: a multicenter case-control study. Chalasani N; Baluyut A; Ismail A; Zaman A; Sood G; Ghalib R; McCashland TM; Reddy KR; Zervos X; Anbari MA; Hoen H Hepatology; 2000 Jan; 31(1):7-11. PubMed ID: 10613720 [TBL] [Abstract][Full Text] [Related]
17. [A contribution to the differential diagnostics of sclerosing cholangitides]. Blaho M; Dítě P; Bojková M; Rydlo M; Kupka T; Svoboda P; Klvaňa P; Martínek A Vnitr Lek; 2017; 63(1):50-55. PubMed ID: 28225291 [TBL] [Abstract][Full Text] [Related]
18. Diagnosis and management of cholangiocarcinoma in primary sclerosing cholangitis. Ahrendt SA; Pitt HA; Nakeeb A; Klein AS; Lillemoe KD; Kalloo AN; Cameron JL J Gastrointest Surg; 1999; 3(4):357-67; discussion 367-8. PubMed ID: 10482687 [TBL] [Abstract][Full Text] [Related]
19. Hepatopancreatobiliary manifestations and complications associated with inflammatory bowel disease. Navaneethan U; Shen B Inflamm Bowel Dis; 2010 Sep; 16(9):1598-619. PubMed ID: 20198712 [TBL] [Abstract][Full Text] [Related]
20. Cholangiocarcinoma in a 17-year-old boy with primary sclerosing cholangitis and inflammatory bowel disease. Deneau M; Adler DG; Schwartz JJ; Hutson W; Sorensen J; Book L; Lowichik A; Guthery S J Pediatr Gastroenterol Nutr; 2011 May; 52(5):617-20. PubMed ID: 21502832 [No Abstract] [Full Text] [Related] [Next] [New Search]